Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.22 | 6.70731707317 | 3.28 | 3.58 | 3.26 | 144798 | 3.44628755 | CS |
4 | 0.18 | 5.42168674699 | 3.32 | 4.1499 | 2.99 | 296110 | 3.44161362 | CS |
12 | -43.5 | -92.5531914894 | 47 | 51.2569 | 2.99 | 391904 | 8.418146 | CS |
26 | -32.71 | -90.3341618337 | 36.21 | 53.79 | 2.99 | 230899 | 17.13490783 | CS |
52 | -12.74 | -78.4482758621 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
156 | -12.74 | -78.4482758621 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
260 | -12.74 | -78.4482758621 | 16.24 | 53.79 | 2.99 | 161898 | 18.31477531 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관